02600oam 2200649K 450 991078213760332120230721032720.00-429-52568-00-429-13772-91-281-73192-797866117319221-4200-5294-2(CKB)1000000000537580(EBL)354105(OCoLC)476175660(SSID)ssj0000220627(PQKBManifestationID)11218565(PQKBTitleCode)TC0000220627(PQKBWorkID)10144025(PQKB)10594449(MiAaPQ)EBC3059666(OCoLC)1039523809(OCoLC-P)1039523809(FlBoTFG)9780429137723(EXLCZ)99100000000053758020170131h20082008 uy 0engurcnu||||||||txtccrPharmacogenetics of breast cancer towards the individualization of therapy /edited by Brian Leyland-JonesNew York :CRC Press,2008.©20081 online resource (352 p.)Translational medicine series ;7Description based upon print version of record.1-4200-8637-5 1-4200-5293-4 Includes bibliographical references and index.Front Cover; Preface; Acknowledgments; Contents; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Chapter 19; Chapter 20; Index; Back Cover; Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become rout.Translational medicine series ;7.BreastCancerGenetic aspectsBreastCancerChemotherapyPharmacogeneticsBreastCancerGenetic aspects.BreastCancerChemotherapy.Pharmacogenetics.616.99449061Leyland-Jones Brian1462946OCoLC-POCoLC-PBOOK9910782137603321Pharmacogenetics of breast cancer3672103UNINA